GlassScriptPhysician profile
Howard Clark Federer
NPI 1023039674
$6,148.67
in general payments reported to CMS, 2019-2025
9 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,031 · 2020: $42.14 · 2022: $3,442 · 2023: $64.81 · 2024: $333 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345 · Education: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.39 |
| Education | $287.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,648.47 | 2019-2025 | |
| Davol INC. | $212.18 | 2019-2025 | Phasix Mesh, Arista Ah Flexitip |
| Kerecis Limited | $73.59 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Integra Lifesciences Corporation | $48.26 | 2022 | |
| Smith+Nephew, INC. | $46.55 | 2019-2025 | Collagenase Santyl |
| Medtronic, INC. | $38.33 | 2023 | Ligasure |
| Dilon Technologies, INC. | $34.69 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.48 | 2023 | Gattex |
| Convatec INC. | $20.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Federer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.